BACKGROUND: : Patients with hepatocellular carcinoma (HCC) have a poor prognosis if their tumors are not diagnosed early. The authors investigated factors associated with the receipt of liver transplant among patients with HCC and evaluated the effects of these differences on survival. METHODS: : The authors reviewed records from consecutive patients diagnosed with HCC at Columbia University Medical Center from January 1, 2002 to September 1, 2008. We compared patient clinical and demographic characteristics, developed a multivariable logistic regression model of predictors of transplant, and used a Cox model to analyze predictors of mortality. RESULTS: : Of 462 HCC patients, 175 (38%) received a transplant. Black patients were much less likely than whites to receive a transplant (odds ratio [OR], 0.03; 95% confidence interval [CI], 0.0-0.37). Hispanics and Asians were also less likely to undergo transplantation, but the differences were not statistically significant. Patients with private insurance were more likely to receive a transplant than those with Medicaid (odds ratio [OR], 22.07; 95% confidence interval [CI], 2.67-182.34). Black and Hispanic patients, and Medicaid recipients, presented with more advanced disease than whites and privately insured patients, and had poorer survival. In a Cox model, those who did not receive a transplant were 3 times as likely as transplant recipients to die, but race and insurance were not independently predictive of mortality. CONCLUSIONS: : Race and insurance status were strongly associated with receipt of transplantation and with more advanced disease at diagnosis, but transplantation was the most important determinant of survival. Improved access to care for nonwhite and Medicaid patients may allow more patients to benefit from transplant. Cancer 2010. (c) 2010 American Cancer Society.
BACKGROUND: : Patients with hepatocellular carcinoma (HCC) have a poor prognosis if their tumors are not diagnosed early. The authors investigated factors associated with the receipt of liver transplant among patients with HCC and evaluated the effects of these differences on survival. METHODS: : The authors reviewed records from consecutive patients diagnosed with HCC at Columbia University Medical Center from January 1, 2002 to September 1, 2008. We compared patient clinical and demographic characteristics, developed a multivariable logistic regression model of predictors of transplant, and used a Cox model to analyze predictors of mortality. RESULTS: : Of 462 HCCpatients, 175 (38%) received a transplant. Black patients were much less likely than whites to receive a transplant (odds ratio [OR], 0.03; 95% confidence interval [CI], 0.0-0.37). Hispanics and Asians were also less likely to undergo transplantation, but the differences were not statistically significant. Patients with private insurance were more likely to receive a transplant than those with Medicaid (odds ratio [OR], 22.07; 95% confidence interval [CI], 2.67-182.34). Black and Hispanic patients, and Medicaid recipients, presented with more advanced disease than whites and privately insured patients, and had poorer survival. In a Cox model, those who did not receive a transplant were 3 times as likely as transplant recipients to die, but race and insurance were not independently predictive of mortality. CONCLUSIONS: : Race and insurance status were strongly associated with receipt of transplantation and with more advanced disease at diagnosis, but transplantation was the most important determinant of survival. Improved access to care for nonwhite and Medicaid patients may allow more patients to benefit from transplant. Cancer 2010. (c) 2010 American Cancer Society.
Authors: J Figueras; E Jaurrieta; C Valls; C Benasco; A Rafecas; X Xiol; J Fabregat; T Casanovas; J Torras; C Baliellas; L Ibañez; P Moreno; L Casais Journal: Hepatology Date: 1997-06 Impact factor: 17.425
Authors: Lawrence E Harrison; Trevor Reichman; Baburao Koneru; Adrian Fisher; Dorian Wilson; Andrew Dela Torre; Arun Samanta; Maria Korogodsky Journal: Arch Surg Date: 2004-09
Authors: John Z Ayanian; Paul D Cleary; Joseph H Keogh; Susan J Noonan; Jo Ann David-Kasdan; Arnold M Epstein Journal: Am J Kidney Dis Date: 2004-02 Impact factor: 8.860
Authors: V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari Journal: N Engl J Med Date: 1996-03-14 Impact factor: 176.079
Authors: Richard S Hoehn; Dennis J Hanseman; Peter L Jernigan; Koffi Wima; Audrey E Ertel; Daniel E Abbott; Shimul A Shah Journal: HPB (Oxford) Date: 2015-09 Impact factor: 3.647
Authors: Rajesh Ramanathan; Amit Sharma; David D Lee; Martha Behnke; Karen Bornstein; R Todd Stravitz; Malcolm Sydnor; Ann Fulcher; Adrian Cotterell; Marc P Posner; Robert A Fisher Journal: Transplantation Date: 2014-07-15 Impact factor: 4.939
Authors: Krystal L Karunungan; Yas Sanaiha; Roland A Hernandez; Holly Wilhalme; Sarah Rudasill; Joseph Hadaya; Joseph DiNorcia; Peyman Benharash Journal: Liver Transpl Date: 2020-12-31 Impact factor: 5.799
Authors: Benjamin Yip; James M Wantuck; Lily H Kim; Robert J Wong; Aijaz Ahmed; Gabriel Garcia; Mindie H Nguyen Journal: Dig Dis Sci Date: 2013-11-27 Impact factor: 3.199
Authors: Omar Hyder; Rebecca M Dodson; Hari Nathan; Joseph M Herman; David Cosgrove; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik Journal: J Am Coll Surg Date: 2013-09-13 Impact factor: 6.113
Authors: Abby B Siegel; Kristina Conner; Shuang Wang; Judith S Jacobson; Dawn L Hershman; Rosa Hidalgo; Elizabeth C Verna; Karim Halazun; William Brubaker; Jonah Zaretsky; Anna Moniodis; Lissette Delgado-Cruzata; Lorna Dove; Jean Emond; Tomoaki Kato; Robert S Brown; Alfred I Neugut Journal: Exp Ther Med Date: 2011-09-19 Impact factor: 2.447